Results 151 to 160 of about 399,367 (396)

Cryo‐Inactivated Cancer Cells Derived Magnetic Micromotors for Tumor Immunotherapy

Advanced Science, EarlyView.
Cryo‐inactivated cancer cell‐based magnetic micromotors are developed for synergistic tumor immunotherapy via magnetic targeting. These micromotors can induce ferroptosis and immunogenic cell death, deliver tumor antigens, and activate the Mn2+‐dependent cGAS‐STING pathway. The system effectively suppresses tumor progression, recurrence, and metastasis,
Qingfei Zhang, Gaizhen Kuang, Wenzhao Li, Yuanjin Zhao   +3 more
wiley   +1 more source

Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia [PDF]

, 1982
Umberto Bertazzoni, Ercole Brusamolino, Paola Isernia, A. Ivana Scovassi, S. Torsello, Mario Lazzarino, Carlo Bernasconi   +6 more
openalex   +3 more sources

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

Haematologica, 2010
Background Micro-RNAs (miRNAs) control gene expression by destabilizing targeted transcripts and inhibiting their translation. Aberrant expression of miRNAs has been described in many human cancers, including chronic myeloid leukemia.
Stéphane Flamant, William Ritchie, Joëlle Guilhot, Jeff Holst, Marie-Laure Bonnet, Jean-Claude Chomel, François Guilhot, Ali G. Turhan, John E.J. Rasko   +8 more
doaj   +1 more source

Leukocyte Kinetics in Chronic Myeloid Leukemia: I. DNA Synthesis Time in Blood and Marrow Myelocytes [PDF]

, 1969
P. C. Vincent, E. P. Cronkite, Michael Greenberg, Christa Kirsten, Lewis M. Schiffer, Pierre Stryckmans   +5 more
openalex   +1 more source

A ROS‐Responsive Dual‐Targeting Drug Nanocarrier Serving as a GSI Synergist and Ferroptosis Sensitizer for T‐Cell Acute Lymphoblastic Leukemia

Advanced Science, EarlyView.
A self‐assembling nanotherapeutic strategy is designed—CD38‐PHD/G‐NPs, which released γ‐secretase inhibitor first, followed by adaptive dihydroartemisnin release in response to elevated reactive oxygen species levels. This controlled, sequential release strategy maximizes the synergistic anti‐leukemic efficacy of two agents with distinct mechanisms of ...
Ruinan Jia, Yang Liu, Jilong Xiao, Yuan Xia, Xin Zhao, Huixian Ma, Jingjing Ye, Zhiyue Zhang, Tao Sun, Chunyan Ji   +9 more
wiley   +1 more source

Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia Treated by Busulfan [PDF]

, 1968
M Djaldetti, J Pinkhas, André de Vries, Edna Kott, H Joshua, L Dollberg   +5 more
openalex   +1 more source

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway

Advanced Science, EarlyView.
This study identifies STAU2 as an oncogenic RNA‐binding protein (RBP) with elevated expression in pancreatic ductal adenocarcinoma (PDAC), where its high levels are significantly correlated with metastatic progression. It elucidates that STAU2 directly binds and regulates PALLD, while mediating the functional role of IQGAP1, thereby driving metastasis ...
Jiayu Ding, Hao Shen, Jiaying Ji, Jiaxing Li, Zhongrui Shi, Xuejiao Wang, Bangbang Li, Yi Hou, Wenjian Min, Chengliang Sun, Kai Yuan, Yasheng Zhu, Liping Wang, Shun‐Qing Liang, Wenbin Kuang, Xiao Wang, Peng Yang   +16 more
wiley   +1 more source

CHRONIC MYELOID LEUKEMIA

Jurnal Kesehatan Tambusai
Chronic Myelogenous Leukemia  (CML) merupakan suatu jenis kanker yang disebabkan oleh gangguan pada hematopoietic stem cell. CML adalah bentuk leukemia yang ditandai dengan peningkatan dan pertumbuhan yang tak terkendali dari sel myeloid pada sumsum tulang.
Akbar, Nugraha Malik, Pratiwi, Rukmanggana Satya, Azmi, Naurah Arika, Supriantarini, Dita, Amatullah, Tazkiyah Arafah, Anggoro, Joko   +5 more
openaire   +4 more sources

High Throughput FISH Analysis: A New, Sensitive Option For Evaluation of Hematological Malignancies

Turkish Journal of Hematology, 2013
OBJECTIVE: The aim of this study was to determine the efficiency of the high throughput FISH analysis (HTFA) method for detecting genetic alterations in hematological malignancies, which is a new bacterial artificial chromosome array-based approach ...
Hakan Savlı, Seda Eren, Nilüfer Üzülmez, Zeynep İlkay, Duygu Yavuz, Deniz Sünnetçi, Abdullah Hacıhanifioğlu, Naci Çine   +7 more
doaj   +1 more source

Frequency of JAK2V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan [PDF]

, 1969
Najia Tabassum Mahfooz, Rubina Ghani, Mohammed Saboor, Moinuddin Moinuddin   +3 more
openalex   +1 more source